Want to see FDMT full AI Analyst Report?
4D Molecular Therapeutics (FDMT) Q3 2023 Earnings Report
FDMT Q3 2023 EPS Results
- Actual EPS
- -$0.24
- Consensus EPS
- -$0.61
- Beat/Miss
- Beat by +$0.37
- One Year Ago EPS
- -$0.79
FDMT Q3 2023 Revenue Results
- Actual Revenue
- $20.20M
- Expected Revenue
- $8.07M
- Beat/Miss
- Beat by +$12.14M
- YoY Revenue Growth
- +3940.80%
Earnings Announcement Details
- Quarter
- Q3 2023
- Date
- 11/09/2023
- Time
- After Close
- Conference Call
- Thursday, November 9, 2023
FDMT Upcoming Earnings
4D Molecular Therapeutics's next earnings date is estimated for November 11, 2026, based on past reporting schedules.
Q3 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
FDMT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 11, 2026 | 2026 (Q3) | -1.05- | -1.01 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | -1.02-1.04 | -0.98 | -6.12% (-0.06) | |
| May 07, 2026 | 2026 (Q1) | -1.00-1.01 | -0.86 | -17.44% (-0.15) | |
| Mar 18, 2026 | 2025 (Q4) | -0.530.43 | -0.89 | 148.31% (+1.32) | |
| Nov 10, 2025 | 2025 (Q3) | -0.98-1.01 | -0.79 | -27.85% (-0.22) | |
| Aug 11, 2025 | 2025 (Q2) | -0.73-0.98 | -0.63 | -55.56% (-0.35) | |
| May 08, 2025 | 2025 (Q1) | -0.87-0.86 | -0.66 | -30.30% (-0.20) | |
| Feb 28, 2025 | 2024 (Q4) | -0.83-0.89 | -0.69 | -28.99% (-0.20) | |
| Nov 13, 2024 | 2024 (Q3) | -0.68-0.79 | -0.24 | -229.17% (-0.55) | |
| Aug 08, 2024 | 2024 (Q2) | -0.68-0.63 | -0.77 | 18.18% (+0.14) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
